David Hung

Insider Reports History

Location
New York, NY
Signature
/s/ Stephen Dang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Hung:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvation Bio Inc. PRESIDENT AND CEO, Director, 10%+ Owner Class A Common Stock 59.3M $106M $1.79 16 Jun 2025 Direct
NovoCure Ltd Director Ordinary Shares 23.4K $420K $17.95 04 Jun 2025 Direct
NovoCure Ltd Director Stock Option (Right to Buy) 16.7K $102K $16.30 04 Jun 2025 Direct
Nuvation Bio Inc. PRESIDENT AND CEO, Director, 10%+ Owner Stock Option (Right to Buy) 2M 28 Feb 2025 Direct
NovoCure Ltd Director Restricted Stock Units 13.2K 05 Jun 2024 Direct

Insider Reports Filed by David Hung

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVB Nuvation Bio Inc. 16 Jun 2025 1 $894K 4 PRESIDENT AND CEO, Director, 10%+ Owner 18 Jun 2025, 16:05
NVCR NovoCure Ltd 04 Jun 2025 2 $0 4 Director 06 Jun 2025, 16:14
NVCR NovoCure Ltd 03 Jun 2025 1 -$17.3K 4 Director 04 Jun 2025, 16:11
NUVB Nuvation Bio Inc. 04 Apr 2025 2 $820K 4 PRESIDENT AND CEO, Director, 10%+ Owner 08 Apr 2025, 21:30
NUVB Nuvation Bio Inc. 28 Feb 2025 1 $0 4 PRESIDENT AND CEO, Director, 10%+ Owner 04 Mar 2025, 18:33
NVCR NovoCure Ltd 05 Jun 2024 2 $0 4 Director 06 Jun 2024, 17:55
NUVB Nuvation Bio Inc. 29 Feb 2024 1 $0 4 PRESIDENT AND CEO, Director, 10%+ Owner 04 Mar 2024, 16:20
NVCR NovoCure Ltd 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:04
NVCR NovoCure Ltd 08 Jun 2022 2 $0 4 Director 10 Jun 2022, 16:11
NUVB Nuvation Bio Inc. 28 Feb 2022 1 $0 4 President and CEO, Director, 10%+ Owner 02 Mar 2022, 13:29
NVCR NovoCure Ltd 09 Jun 2021 2 $0 4 Director 11 Jun 2021, 16:19
NUVB Nuvation Bio Inc. 02 Mar 2021 2 $0 4 President and CEO, Director, 10%+ Owner 02 Mar 2023, 17:01